An observational study in HIV Infections and Sexual Behavior, sponsored by Hektoen Institute for Medical Research. Recruiting at 1 site in United States. Open to participants aged 13 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-08.
Sponsored by Hektoen Institute for Medical Research · Observational
Despite advances in HIV diagnostics, care and prevention strategies, infection rates among adolescent and young adult sexual and gender minorities (SGM) continue to rise in the United States (US). There is an urgent need to describe the epidemiology and trajectories of HIV acquisition in this population and to offer age and culturally appropriate scalable prevention interventions to those at highest risk of infection in the US. This project will engage and retain young SGM in an innovative longitudinal cohort, enroll participants in a dynamic established digital health retention platform (HMP; HealthMPowerment), monitor HIV risk and prevention behaviors and explore the socioecological factors that influence the use of new HIV prevention technologies (UG3 phase), while also allowing targeted testing of novel digital health interventions (UH3 phase). In Aim 1, the investigators will enroll and retain a large (n=6000; 3000/year), diverse cohort of sexually active, SGM adolescents and young adults, ages 13-34, using innovative digital recruitment, engagement and retention strategies. Over the course of the study, the investigators will longitudinally characterize the sexual behavior, HIV transmission risk, and PrEP uptake trajectories of SGM youth utilizing epidemiological trajectory analyses to identify the most effective points of intervention (Aim 2). This study will capitalize upon productive existing partnerships and digital health expertise to articulate the drivers of the ongoing HIV epidemic among the most vulnerable populations in the US in order to identify the most effective, expeditious and scalable strategies to address this ongoing public health crisis.
4,340 studies on the registry are indexed under HIV Infections; 240 are open to participants now.
This study's planned enrollment of 6,000 is above the median of 200 across 731 observational studies indexed under HIV Infections.
Browse HIV Infections studies →Hektoen Institute for Medical Research is the lead sponsor of 7 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Self-identified sexual and gender minority adolescents and young adults ages 13-34.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For young adults ages 18-34: self-identified SGM young adults ages 18-34 who meet at least one of the following criteria:
Exclusion Criteria:
observational cohort only
Sexual Behavior Questionnaire
oral, anal and vaginal sex episodes
Time frame: past 6 months
HIV Testing Result
HIV seroconversion
Time frame: past 12 months
PrEP uptake
initiation of pre-exposure prophylaxis for HIV prevention
Time frame: past 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hektoen Institute for Medical Research